ArticleFuture science OA2026
Long-term palliation of combined malignant gastric outlet and biliary obstruction by using sequentially enteral stents and EUS-guided antegrade biliary and lumen-apposing gastrojejunal stents.
Article in Future science OA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For unresectable advanced gastric malignancies causing malignant gastric outlet obstruction(GOO) and malignant biliary obstruction(MBO), traditional treatment methods include surgical gastrojejunostomy and hepatojejunostomy. However, surgical treatment is associated with many complications and prolonged recovery. We report a case of a 56-year-old male patient who complained of nausea and vomiting after meals for one month. Esophagogastroduodenoscopy(EGD) revealed a malignant gastric tumor, pyloric obstruction, and gastric retention. Abdominal CT revealed multiple liver metastases and distant lymph nodes metastases. Two duodenal stents were placed within two months to relieve the malignant GOO. Five months later, rapid tumor progression led torecurrent malignant GOO and involvement of the duodenum, resulting in MBO. Since endoscopic retrograde cholangiopancreatography(ERCP) was not feasible, we relieved the MBO through endoscopic ultrasound guided antegrade stenting (EUS-AS). One week later, GOO was treated with endoscopic ultrasound guided gastroenterostomy (EUS-GE). During the 6-month follow-up period, the patient experienced no recurrence of obstructive jaundice or gastric retention, and the treatment was effective. Endoscopic stent placement can relieve malignant double obstruction,with minimal complications and rapid recovery. Endoscopic interventions are repeatable and provide immediate and reliable clinical benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.